A carregar...
Projeto de investigação
Production and Testing of humAn-derived Neurons and brain organoids: advanced model probing in neurodevelopmental disorders
Financiador
Autores
Publicações
CASPR2 autoimmune antibodies modify the developmental trajectory and network activity in human brain organoids
Publication . Oliveira, Ana Rafaela Gomes Soares; Silvestre, João; Ferreira, Lino; Crespo, João
Recent decades have seen great expansion on our understanding on how neurons
communicate and process information, however, limited access to human brain
samples is a critical aspect preventing a greater understanding on the cellular and
molecular mechanisms underlying brain diseases. Additionally, animal models and in
vitro two-dimensional (2D) cell cultures fail to mimic the unique cellular and molecular
physiology of the human brain. Recently, the development of human brain organoids has
presented a new tool that may facilitate the study of functional human synapses and
neuronal networks, that may further our understanding of disease mechanisms.
Gestational transfer of brain-reactive antibodies is an important environmental risk
factor triggering neurodevelopmental disorders. CASPR2 is encoded by CNTNAP2, an
autism susceptibility gene and is a known target for pathogenic maternal autoantibodies
that can interfere with fetal neurodevelopment. CASPR2 was originally described to be
involved in the stabilization of voltage-gated potassium channels (Kv1.1 and Kv1.2) in
myelinated axons, and later to have a role in earlier phases of rodent brain development.
However, the effects induced by the presence of anti-CASPR2 antibodies (anti-CASPR2-
Ab) during human brain development have not yet been addressed.
To tackle this gap in knowledge we cultured human brain organoids for a period of
up to 6-months in media containing human anti-CASPR2-Ab. We found that this
challenge produced a decrease in CASPR2 and Contactin-2 protein levels, altered
spontaneous synaptic activity, and led to an increase in the frequency of action potential
firing upon current injection. These alterations were consistent with change in action
potential kinetics, suggestive of altered function in voltage-gated potassium channels.
In line with these observations, we also observed an overall increase in network activity
in acute brain organoid slices.
In parallel with this work, we also produced brain organoids from human induced
pluripotent stem cells (hiPSCs) generated de novo from individuals carrying a genetic
mutation associated with a neurological disease. The resulting mutated organoids
recapitulated the genetic and molecular features of the original patients’ cells and offer
a platform for further studying the mechanisms associated with the disease.
Therefore, our data highlights the value of using brain organoids as robust
models to study brain development and neurological disorders. These models may
ultimately allow us to interpret the underlying neurobiological mechanisms associated
with several disorders and lay the groundwork for identifying and testing novel
therapeutic approaches.
Unidades organizacionais
Descrição
Palavras-chave
Contribuidores
Financiadores
Entidade financiadora
European Commission
Programa de financiamento
H2020
Número da atribuição
799164
